Osteolytic Neoplasm — Trials

Osteolytic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00396279	Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone	completed	Phase 2	37	AmgenINDUSTRY	0	Nov 8, 2022	clinicaltrials
NCT00680992	Study of Denosumab in Subjects With Giant Cell Tumor of Bone	completed	Phase 2	535	AmgenINDUSTRY	12	Sep 22, 2022	clinicaltrials
NCT00464620	Trial of Dasatinib in Advanced Sarcomas	completed	Phase 2	366	Sarcoma Alliance for Research through CollaborationOTHER	1	Nov 23, 2018	clinicaltrials
NCT03415477	Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts(Deno-ABC)

Data updated 22 days agoSource updated Nov 8, 2022source: clinicaltrials